asiatic acid has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JY; Huang, ZH; Xu, H; Xu, QW | 1 |
| Huh, K; Jeong, TC; Jin, DQ; Kim, JA; Kwon, EJ; Lee, ES; Lee, YS; Nam, DH; Park, SH | 1 |
2 other study(ies) available for asiatic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Asiatic acid promotes p21(WAF1/CIP1) protein stability through attenuation of NDR1/2 dependent phosphorylation of p21(WAF1/ CIP1) in HepG2 human hepatoma cells.
Topics: Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Humans; Immunoprecipitation; Liver Neoplasms; Pentacyclic Triterpenes; Phosphorylation; Protein Serine-Threonine Kinases; Protein Stability; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2014 |
Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Pentacyclic Triterpenes; Triterpenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |